News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

US FDA to Seek Panel's Advice on Q-Med AB's Studies


8/17/2009 7:25:38 AM

Bookmark and Share

Reuters -- U.S. Food and Drug Administration staff is seeking a panel's review of Q-Med AB's studies of its Durolane injection for arthritis knee pain, according to documents released ahead of the panel's meeting on Wednesday.

Read at Reuters

comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES